Recently merged CRO Clinipace raises $50M in new funding
Clinical research firm Clinipace, which recently merged with Shanghai-based dMed, has closed on $50 million in new funding from three primary backers.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed